Monalizumab Withdrawn Phase 2 Trials for Microsatellite Stable (MSS) Colorectal Cancer (CRC) Treatment

Indications	Status	Purpose	Phase
DBCOND0130188 (Microsatellite Stable (MSS) Colorectal Cancer (CRC))	Withdrawn	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT04145193	Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC	Durvalumab (DB11714) Fluorouracil (DB00544) Leucovorin (DB00650) Monalizumab (DB12824) Oleclumab (DB15088) Oxaliplatin (DB00526)